Clinical Genitourinary Cancer
(CLIN GENITOURIN CANC) 《临床泌尿系统肿瘤》
网友评分点击次数：1237
2014年影响因子
2.322
推荐阅读
- 2013-12-30•舒尼替尼标准 vs. 调整剂量方案治疗转移性肾细胞癌：来自大型回顾性分析的结果
- 2013-08-09•舒尼替尼治疗转移性肾细胞癌的长期效果
- 2013-08-09•社区-医学院转移性肾细胞癌患者队列在真实世界中的治疗现状：一、二、三线治疗的无进展生存期。
- 2013-04-19•通过比较尿液蛋白质组学和分析发现潜在膀胱癌生物标记物
- 2013-04-19• T1期透明细胞肾细胞癌延迟复发预测因素：一项多中心研究
- 2013-04-19•龟头纤维上皮息肉内恶性退化：病例报告和文献回顾
- 2013-04-19•一名接受舒尼替尼治疗的肾细胞癌患者中的致死性肝衰竭
- 2013-04-19•既往接受血管内皮生长因子酪氨酸激酶抑制剂治疗的转移性肾细胞癌患者中贝伐单抗单药的活性
- 2013-04-19•接受长期化学去势治疗男性中复杂代谢和骨骼改变
目录导读
Published 2013年3月,Volume 11,Issue 1
最新一期
| Article Title | Author(s) | Pages | ||
|---|---|---|---|---|
A “Game of Thrones” in Metastatic Renal Cell Carcinoma: Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors and Mammalian Target of Rapamycin Inhibitors Battling for Position
|
Sumanta Kumar Pal, Nicholas J. Vogelzang | 1-4 | ||
| Reviews | ||||
| Article Title | Author(s) | Pages | ||
Positive Surgical Margins After Nephron-Sparing Surgery for Renal Cell Carcinoma: Incidence, Clinical Impact, and Management
|
Marco Borghesi, Eugenio Brunocilla, Riccardo Schiavina, Giuseppe Martorana | 5-9 | ||
Bcl-2 Family of Proteins as Therapeutic Targets in Genitourinary Neoplasms
|
Connor Hall, Sarah M. Troutman, Douglas K. Price, William D. Figg,et al. | 10-19 | ||
| Original Studies | ||||
| Article Title | Author(s) | Pages | ||
Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
|
Sten Nilsson, Lars Franzén, Christopher Parker, Christopher Tyrrell, et al. | 20-26 | ||
Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
|
Patrick Berkovic, Gert De Meerleer, Louke Delrue, Bieke Lambert, et al. | 27-32 | ||
Complex Metabolic and Skeletal Changes in Men Taking Long-Term Androgen Deprivation Therapy
|
Stanislav Ziaran, Frederico M. Goncalves, Jan Breza Sn | 33-38 | ||
Upper Urinary Tract Transitional Cell Carcinoma: Is There a Best?
|
Levent Mert Gunay, Bulent Akdogan, Artan Koni, Kubilay Inci,et al. | 39-44 | ||
Activity of Single-Agent Bevacizumab in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors
|
James D. Turnbull, Julien Cobert, Tracy Jaffe, Michael R. Harrison, et al. | 45-50 | ||
Predictive Factors for Late Recurrence in Patients With Stage T1 Clear Cell Renal Cell Carcinoma: A Multiinstitutional Study
|
Yun-Sok Ha, Yong Hyun Park, Seok Ho Kang, Sung-Hoo Hong,et al. | 51-55 | ||
Discovery of Potential Bladder Cancer Biomarkers by Comparative Urine Proteomics and Analysis
|
Ting Lei, Xuhong Zhao, Sheng Jin, Qian Meng, et al. | 56-62 | ||
| Case Reports | ||||
| Article Title | Author(s) | Pages | ||
Malignant Degeneration Within a Fibroepithelial Polyp of the Glans Penis: A Case Report and Literature Review
|
Spyridon Kampantais, Victoras Gourvas, Stefania Lymperi, Chrysovalantis Toutziaris, et al. | 63-65 | ||
False Positive 2-18Fluroro-deoxy-D-Glucose Positron Emission Tomography (FDG-PET) in Patients With Disseminated Seminoma and Post-Chemotherapy Residual Masses
|
Mathilde Wagner, Joaquim Bellmunt, Celine Boutros, Gerald Bonardel, et al. | 66-69 | ||
Fatal Liver Failure in a Patient Treated With Sunitinib for Renal Cell Carcinoma
|
Willmosh Mermershtain, Irena Lazarev, Noa Shani-Shrem, Samuel Ariad | 70-72 | ||
| Frontmatter | ||||
| Article Title | Author(s) | Pages | ||
Editorial Board
|
A3 | |||
Table of Contents
|
A4-A5 | |||
发表评论网友评论(0)
